Stockscreener 앱 받기
2.37
3.49%
0.08
시간 외 거래:
2.37
전일 마감가:
$2.29
열려 있는:
$2.33
하루 거래량:
246.25K
Relative Volume:
0.77
시가총액:
$200.81M
수익:
$25.14M
순이익/손실:
$-21.57M
주가수익비율:
-8.7778
EPS:
-0.27
순현금흐름:
$-12.23M
1주 성능:
+3.49%
1개월 성능:
+6.76%
6개월 성능:
+32.40%
1년 성능:
+26.74%
1일 변동 폭
$2.27
$2.40
1주일 범위
$2.21
$2.40
52주 변동 폭
$1.66
$3.29
Stereotaxis Inc Stock (STXS) Company Profile
명칭
Stereotaxis Inc
전화
314-678-6100
주소
4320 Forest Park Avenue, Suite 100, St. Louis, MO
STXS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STXS
Stereotaxis Inc
|
2.37 | 200.81M | 25.14M | -21.57M | -12.23M | -0.27 |
|
ISRG
Intuitive Surgical Inc
|
535.29 | 190.66B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
228.46 | 66.26B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
84.06 | 41.58B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
231.67 | 34.01B | 4.81B | 1.11B | 1.35B | 7.55 |
|
WST
West Pharmaceutical Services Inc
|
335.56 | 24.30B | 2.88B | 499.60M | 321.60M | 6.74 |
Stereotaxis Inc Stock (STXS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-01-10 | 개시 | ROTH MKM | Buy |
| 2022-07-12 | 개시 | Aegis Capital | Buy |
| 2022-06-23 | 개시 | B. Riley Securities | Buy |
| 2022-01-05 | 개시 | Craig Hallum | Buy |
| 2022-01-05 | 개시 | Loop Capital | Buy |
| 2021-05-26 | 개시 | Piper Sandler | Overweight |
| 2020-09-08 | 개시 | Northland Capital | Outperform |
| 2020-04-09 | 개시 | Cowen | Outperform |
| 2020-04-07 | 개시 | Lake Street | Buy |
모두보기
Stereotaxis Inc 주식(STXS)의 최신 뉴스
State Street Corp Acquires 36,518 Shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS) - Defense World
Charles Schwab Investment Management Inc. Boosts Stock Position in Stereotaxis, Inc. (NYSEAMERICAN:STXS) - Defense World
STXS Stock Up Post NMPA Nod for Cardiovascular Care With Magbot - MSN
Stereotaxis (STXS) Stock Surges Amid Positive Ratings in Medical Device Sector - GuruFocus.com
Stereotaxis (NYSEAMERICAN:STXS) Shares Down 2.2%Here's What Happened - MarketBeat
Items Tagged with 'endovascular robotics' - BioWorld Online
Items Tagged with 'atrioventricular nodal reentrant tachycardia' - BioWorld Online
China clears Stereotaxis/Microport’s robotic ablation catheter - BioWorld Online
NMPA approves Stereotaxis and MicroPort’s ablation catheter - Yahoo Finance
Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China’s NMPA - GlobeNewswire
Stereotaxis Secures Crucial NMPA Approval for Revolutionary Magnetic Ablation Catheter in China - StockTitan
Stereotaxis’ GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems - GlobeNewswire
Stereotaxis? GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems - Marketscreener.com
Stereotaxis To Drive Transformational Growth Via Full Ecosystem Launch In 2025 - Seeking Alpha
Stereotaxis surgical robot gets regulatory nod in China - Robot Report
Stereotaxis to Participate in Piper Sandler 36th Annual Healthcare Conference - GlobeNewswire
Pre-Market Momentum For Stereotaxis (STXS) Following Key Approval - Stocks Telegraph
Stereotaxis’ Genesis Surgical Robot OK’ed in China - MPO-mag
Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China - GlobeNewswire
Stereotaxis Secures China NMPA Approval for Genesis Robotic Surgery System - StockTitan
Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System - GlobeNewswire
Stereotaxis Genesis Robotic System Debuts at Portugal's Leading Cardiac Center | STXS Stock News - StockTitan
FY2024 EPS Estimates for Stereotaxis Reduced by Roth Capital - MarketBeat
Stereotaxis Inc (STXS) Quarterly 10-Q Report - Quartzy
STXS Stock Drops 5% Despite Strong Buy Ratings from Analysts - GuruFocus.com
Stereotaxis Reports Strong Q3 Growth in Robotics - Yahoo Finance
Stereotaxis Inc. (STXS) Reports Q3 Loss, Tops Revenue Estimates - MSN
Stereotaxis, Inc. (AMEX:STXS) Q3 2024 Earnings Call Transcript - Insider Monkey
Stereotaxis Reports 2024 Third Quarter Financial Results - The Manila Times
Stereotaxis earnings missed by $0.03, revenue topped estimates - Investing.com UK
Stereotaxis Q3 Revenue Surges 18% as GenesisX Robotic System Gains CE Mark | STXS Stock News - StockTitan
Kansas hospital begins robotic heart program with Stereotaxis surgical robot - Robot Report
Robotic Catheter Systems Market Expected to See Prominent - openPR
Stereotaxis Inc (STXS) Q3 2024: Everything You Need To Know Ahea - GuruFocus.com
Kansas health centre adopts Stereotaxis’ endovascular robot - Medical Device Network
University of Kansas Medical Center Enhances Robotic Heart Care Program with Genesis Robotic Technology - GlobeNewswire
Stereotaxis Genesis Robot System Launches at Kansas Health, Marks Major Expansion | STXS Stock News - StockTitan
Global Medical Robot Market to Reach USD 38701.5 Million by 2034 at a 12.9% of CAGR, Driven by Break - PharmiWeb.com
Stereotaxis to Report Third Quarter 2024 Financial Results on November 11, 2024 - GlobeNewswire
STXSStereotaxis, Inc. Latest Stock News & Market Updates - StockTitan
Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation - GlobeNewswire
Congenital Heart Defect Devices Market Advancements Highlighted by Report 2024: Size, Growth, Key Players, ... - WhaTech
Electrophysiology Catheters Market 2024: Growth Drivers, Technological Innovations, and Competitive Landscape - WhaTech
Stereotaxis Inc (STXS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.64%
0.11%
자본화:
|
볼륨(24시간):